Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
SCOTUS Declines to Get Involved in Maryland Drug “Price Gouging” Law
Earlier this year, the Supreme Court of the United States declined to hear a case involving a Maryland law that attempted to…
House Subcommittee Holds Fiery Hearing on Generic Competition
On Wednesday, March 13, 2019, the House Energy and Commerce Subcommittee on Health held a hearing to discuss a slate of bills, all…
Pfizer Settles with Oregon Over Drug Price Coupons
On March 11, 2019, Oregon Attorney General Ellen F. Rosenblum announced a nearly-$1 million settlement ($975,000.00) with Pfizer…
January MedPAC Recommendations: Rebates & Biosimilars
The Medicare Payment Advisory Commission (MedPAC), responsible for advising Congress on Medicare issues, held its January 2019…
Industry CEOs Testify at Senate Finance Hearing
On Tuesday, February 26, 2019, the Senate Finance Committee held a hearing on drug costs and potential policy solutions to bring…
Industry Offering Larger Prescription Discounts
While the headlines of the year tend to focus on the fact that some pharmaceutical companies are raising their list prices,…
300 Drugs Now Under Investigation in “Generic Drug Cartel”
What began at the end of 2016 as an antitrust lawsuit has now exploded into an investigation of alleged price-fixing involving at…
California Governor Laser-Focused on Drug Prices
As one of his very first acts as Governor of California, Gavin Newsom signed an executive order that directed state officials to…
Bipartisan Legislation Drafted on New Payment Models
Senators Bill Cassidy, a Republican from Louisiana, and Mark Warner, a Democrat from Virginia, have teamed up and are seeking…
Aggressive Drug Pricing Proposals Introduced in Congress
As drug prices continue to be a hot news subject, legislative proposals to stymie the climb to higher prices are sure to be…